CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...
The FDA approved Spravato for those battling depression and has seen little to no improvement from two types of ...
The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback